RxLink Pharmaceuticals

 

RxLink Pharmaceuticals

Pharmaceutical Innovations for the Future

R & D

RxLink Pharmaceuticals R & D

West Palm Beach, FL

 

May 3, 2022 – The FDA approved a REMS Modification, and SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX tablets are now covered under the Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) REMS Program.

Contact RxLink

Let us know how to get back to you.

How can we help?

Feel free to ask a question or simply leave a comment.